A case study and proposal for publishing directed acyclic graphs: The effectiveness of the quadrivalent human papillomavirus vaccine in perinatally HIV Infected girls

Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus–infected and Exposed, Uninfected Youth

(2019) Anna-Barbara Moscicki et al.   CLINICAL INFECTIOUS DISEASES

Clinical implications of the interaction between HPV and HIV infections

(2018) Greta Dreyer   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study

(2018) Erna Milunka Kojic et al.   JOURNAL OF INFECTIOUS DISEASES

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis

(2018) Chunqing Lin et al.   LANCET INFECTIOUS DISEASES

Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis

(2018) Helen Kelly et al.   Lancet HIV

First analysis of ‘pre-registered’ studies shows sharp rise in null findings

(2018) Matthew Warren   NATURE

Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results

(2018) Philip E. Castle et al.   PREVENTIVE MEDICINE

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

(2017) Kimberley Kavanagh et al.   LANCET INFECTIOUS DISEASES

Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines

(2016) Helena Faust et al.   VACCINE

Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study

(2016) Katherine Tassiopoulos et al.   BMJ Open

HPV vaccines: Translating immunogenicity into efficacy

(2015) Taylor B. Turner et al.   Human Vaccines & Immunotherapeutics

Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives

(2014) Lars Toft et al.   Sexual Health

Inequalities in the uptake of Human Papillomavirus Vaccination: a systematic review and meta-analysis

(2013) Harriet Fisher et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study

(2013) Lynette Denny et al.   VACCINE

End-of-study safety, immunogenicity and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

(2011) X Castellsagué et al.   BRITISH JOURNAL OF CANCER

The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research

(2010) Lara F Bratcher et al.   Infectious Agents and Cancer

Invited Commentary: Causal Diagrams and Measurement Bias

(2009) M. A. Hernan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY